Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
An index measures a segment of the stock market, aggregating prices or returns. Learn what it reveals about market trends.
27,998 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A volatile oil backdrop in mid-2026 is creating a rare entry point for Exxon Mobil. With disciplined costs and robust...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
Oracle plunges after earnings, amplifying a sell-off in cloud software as the company unveils a $40 billion capital r...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
As AI infrastructure names retreat from spring highs, June market conditions and resilient AI demand are prompting in...
February market action favors growth names as earnings beat and cash flow strengthens. This report highlights three h...
Super Micro Computer beat expectations on adjusted earnings and guided higher for Q4 revenue, while unveiling a nucle...
Two high-growth names face near-term headwinds. This guide explains why patient investors could benefit from the pull...
Joby Aviation is set to report Q4 2025 results after the close, and the focal point for investors is cash burn. The c...
AppLovin is set to report Q1 2026 after the close, with traders eyeing revenue momentum, margins and AI advertising s...
A single company’s three engines—cloud, ads, and chips—are powering a persistent multi‑billion revenue trajectory, ev...